0001209191-20-020512.txt : 20200320 0001209191-20-020512.hdr.sgml : 20200320 20200320175541 ACCESSION NUMBER: 0001209191-20-020512 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200319 FILED AS OF DATE: 20200320 DATE AS OF CHANGE: 20200320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KENYON LAWRENCE A CENTRAL INDEX KEY: 0001230484 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37759 FILM NUMBER: 20733095 MAIL ADDRESS: STREET 1: C/O OUTLOOK THERAPEUTICS, INC. STREET 2: 7 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Outlook Therapeutics, Inc. CENTRAL INDEX KEY: 0001649989 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 383982704 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 7 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: 6096193990 MAIL ADDRESS: STREET 1: 7 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 FORMER COMPANY: FORMER CONFORMED NAME: Oncobiologics, Inc. DATE OF NAME CHANGE: 20150804 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-19 0 0001649989 Outlook Therapeutics, Inc. OTLK 0001230484 KENYON LAWRENCE A C/O OUTLOOK THERAPEUTICS, INC. 7 CLARKE DRIVE CRANBURY NJ 08512 1 1 0 0 CEO, Pres, CFO, Treas & Secy Stock Option (Right to Buy) 0.54 2020-03-19 4 A 0 216435 0.00 A 2030-03-19 Common Stock 216435 216435 D The options were granted under the Issuer's 2015 Equity Incentive Plan (the "2015 Plan") and shall vest in four equal installments beginning on March 19, 2021 such that the option shall be vested in full on March 19, 2024, subject to the Reporting Person providing continuous service to the Issuer on each such date, and subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer through such event. /s/ Lawrence Kenyon 2020-03-20